Variable | All-day group (n = 206) | Non-all-day group (n = 199) | P value |
---|---|---|---|
Age, year, mean ± SD | 63.2 ± 14.1 | 66.3 ± 15.1 | 0.034 |
Sex, male, n (%) | 140 (68.0) | 122 (61.3) | 0.161 |
BMI, kg/m2, mean ± SD | 21.9 (3.7) | 22.2 (3.9) | 0.311 |
CCI, mean ± SD | 5.4 (2.7) | 5.6 (2.8) | 0.582 |
Comorbidities, n (%) | |||
Cardiovascular disease | 33 (16.0) | 24 (12.1) | 0.252 |
Chronic respiratory disease | 20 (9.7) | 25 (12.6) | 0.361 |
Chronic neurologic disease | 21 (10.2) | 38 (19.1) | 0.011 |
Chronic liver disease | 23 (11.2) | 31 (15.6) | 0.192 |
Diabetes | 62 (30.1) | 58 (29.1) | 0.834 |
Chronic renal disease | 20 (9.7) | 25 (12.6) | 0.361 |
Connective tissue disease | 1 (0.5) | 4 (2.0) | 0.209 |
Immunosuppressed | 10 (4.9) | 13 (6.5) | 0.466 |
Hematologic malignancy | 46 (22.3) | 38 (19.1) | 0.422 |
Solid cancer | 105 (51.0) | 80 (40.2) | 0.030 |
Suspected site of infection, n (%)* | |||
Pulmonary | 63 (30.6) | 82 (41.2) | 0.026 |
Gastrointestinal | 83 (40.3) | 55 (27.6) | 0.007 |
Urinary | 15 (7.3) | 26 (13.1) | 0.054 |
Skin/soft tissue | 11 (5.3) | 4 (2.0) | 0.076 |
Other site** | 38 (18.4) | 41 (20.6) | 0.584 |
Positive blood cultures, n (%) | 66 (32.0) | 50 (25.1) | 0.124 |
MRSA | 0 (0.0) | 4 (2.0) | 0.057 |
MDR GNB | 4 (1.9) | 2 (1.0) | 0.685 |
VRE | 21 (10.2) | 9 (4.5) | 0.029 |
Septic shock by Sepsis 3, n (%) | 108 (52.4) | 58 (29.1) | < 0.001 |
SOFA score, mean ± SD | 6.6 ± 2.7 | 6.3 ± 3.3 | 0.091 |
Serum lactate, mmol/l, mean ± SD | 4.1 ± 3.4 | 3.6 ± 2.8 | 0.145 |